Clinical Trial Update: Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule [Phase 1]

View source ↗

Summary

A Phase 1 crossover study evaluated the relative bioavailability and bioequivalence of niraparib tablets compared with niraparib capsules in neoplasms. The resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Tesaro, Inc. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2024-04-26